CSR Program: Improving Access to Care for Women | Takeda Pharmaceuticals

Group of people discussing

Improving access to sustainable, women-centered care for hard-to-reach women and girls

Building comprehensive sexual and reproductive health services by strengthening workforce capacity, health systems and community support mechanisms

Ipas logo

The Program

Partner: Ipas

Budget: 999 million yen

Term: 4 years

Launch: 2022

Area: Ethiopia, Indonesia, Pakistan

Visit the Ipas websiteGo to https://www.ipas.org/

Women and girls in some of the world’s most remote, fragile, and otherwise hard-to-reach areas often lack access to quality sexual and reproductive health (SRH) care which can lead to unintended pregnancies, death and injuries from unsafe abortions, and other potential loss of educational and economic opportunities. This program aims to improve access to and use of comprehensive sexual and reproductive health services for hard-to-reach women and girls in Ethiopia, Indonesia and Pakistan by integrating clinical training and mentorships that are grounded in women-centered care principles.

a group of women surround another women which is talking

Photo Credit: Richard Lord for Ipas

Have more questions?

Contact us if you'd like more information about our Global CSR Program.

Banner Image Credit: Ipas Pakistan